Biotech, or biotechnology, is defined as the exploitation and use of biological processes for industrial, commercial and other requirements, especially the genetic manipulation of microorganisms for the generation, production and development of medicinal elements like antibiotics and hormones which can be used for therapeutic use. It is the technology that uses biological systems, living organisms or their parts to build and develop different products. The specialized sub-sector falls within the larger health care sector and involves activities like drug development, research, manufacturing and marketing in the field of biotech. Among the big basket of Biotech stocks, which ones generated the top returns this year? Which of those figured among the winners in the long list of Biotech stocks? This article provides a list of Biotech stocks which have generated the highest returns in the year 2021 so far. till date of writing. The list is prepared based on the percentage returns generated by the individual Biotech stocks between the end of the previous year and Apr 16, 2021, and the top 10 return generating Biotech stocks are listed below.
Try our new Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Biotech sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) KemPharm, Inc. (KMPH)
There's more... See price performance, YTD-gains, market-cap and other details of all the 522 Biotech stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Biotech ETFs.
Here's a look at the basic details and how the above mentioned stocks fared during the period:
KemPharm
KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of KemPharm. The Iowa, IA-headquartered company KemPharm, Inc. (KMPH) is ranked number one among the best performing stocks of Biotech of 2021. The Health Care sector business falls under the Major Pharmaceuticals industrial sub-sector. Since the start of the year 2021, the stock price of KemPharm has changed by 1094.44 percent, which is calculated based on the previous year's closing price of $0.72 per share and year-to-date closing price of $8.6 per share as of writing. The market value of the company as indicated by its market-cap changed from $3.27 million to $244.04 million during the same period. Along with Biotech, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Healthcare, Wilshire 5000, among other usual products and services. KemPharm continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Acorda Therapeutics
Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Acorda Therapeutics. During the given months of the year 2021, Acorda Therapeutics, Inc. (ACOR) was successful in generating YTD returns of 507.16 percentage which helped it gain the number two spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the New York, NY-based Acorda Therapeutics closed at a price of $0.69 per share, while it traded at a price of $4.19 per share as of Apr 16, 2021. The company's market cap changed from $39.25 million to $39.76 million during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators.
The company is classified under the Health Care industry sector and further specialized as a Biotech Biological Products sector business.
Moleculin Biotech
Moleculin Biotech, Inc., incorporated on July 28, 2015, is a preclinical and clinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. The Companys lead drug ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Moleculin Biotech. Rank number three in the coveted list is held by Moleculin Biotech, Inc. (MBRX) for being among the top performing stocks of 2021. Headquartered in Texas, TX, the Health Care sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2021, stock of Moleculin Biotech has so far gained 331.56 percentage, based on the previous year's closing price of $0.8 per share and year-to-date price of $3.44 per share. During the same period, the market capitalization of the company changed from $49.79 million to $103.25 million.
Aclaris Therapeutics
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Aclaris Therapeutics. At number four in the list of top stocks stands Aclaris Therapeutics, Inc. (ACRS), which saw a change in its stock price from the level of $6.47 apiece during previous year December end to the price of $26.68 per share as of Apr 16, 2021. It translates to a change of 312.36 percentage. The Pennsylvania, PA-headquartered Health Care sector company also saw its market value change from $277.69 million to $1.38 billion. The Major Pharmaceuticals specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.
Pandion Therapeutics
Pandion Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing various therapeutics to address the unmet needs of patients ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Pandion Therapeutics. The Watertown, Massachusetts-based Healthcare sector company Pandion Therapeutics, Inc. (PAND) holds the number five spot among the best performing stocks of the Biotech sector. Classified as the Biotechnology business, the stock price of Pandion Therapeutics ended the previous year at a price of $14.85 per share while it reached the level of $60.05 apiece as of Apr 16, 2021 translating to a percentage change in stock price of 304.38%. As of writing, the company's market-cap value stands at $1.77 billion.
Intrexon
Intrexon Corporation (Intrexon), incorporated on May 21, 2014, forms collaborations to create biologically-based products and processes using synthetic biology. The Companys domestic operations are in California, Florida, Maryland, and Virginia, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Intrexon. Intrexon Corporation (XON) has moved by 247.99 percentage over the given period of 2021-YTD, helping it gain a place at number six among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $5.48 apiece to the price of $19.07 per share between the end of December of the previous year and Apr 16, 2021. The smart run of the Germantown, MD, United States-based Biotech-Commercial Physical Biological Research sector company lead to a handsome gain in its marketcap which changed from $891.5 million to $3.24 billion over the same duration. Intrexon is a key member of many popular stock market indexes. They include Wilshire 5000 index, and several other broader level multi-cap market indicators.
Rubius Therapeutics
Rubius Therapeutics, Inc. focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases through its rubius erythrocyte design cellular therapy platform. The company is developing various RCTs, such as RTX-134 for treatment of classic and moderate phenylketonuria; RTX-Uricase 002FURAT1 for treatment of chronic ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Rubius Therapeutics. The number seven spot in the list of top performing stocks of the Biotech sector is taken by Rubius Therapeutics, Inc. (RUBY). The company's stock price changed from $7.59 per share at the end of December of the previous year to the price of $24.3 per share as of writing. Overall, the stock managed to realized price change of 220.16 percent during the given time period. The corresponding change in the market capitalization value of the USA-based Health Care sector company was from $614.21 million to $2.14 billion. Being ranked in the top 10 best performing stocks of the Biotech sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Wilshire 5000 index, Russell 2000 index, and a handful of other multi-capitalization indexes.
Entera Bio
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Entera Bio. Entera Bio (ENTX) generated percentage returns of 177.78 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $1.08 per share from the previous year-end to the price of $3 per share as of Apr 16, 2021. The company's value, as indicated by the market-cap figure, changed from $19.83 million to $71.1 million during the same period. The company is categorized as a Health Care speciality business with further classification in the Healthcare sub-category. Based in Jerusalem, , the YTD performance of the Biotech sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.
Sunesis Pharma
Sunesis Pharmaceuticals, Inc., incorporated on February 10, 1998, is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Sunesis Pharma. The California, CA-based Sunesis Pharmaceuticals, Inc. (SNSS) belongs to the Health Care sector and is categorized as a Major Pharmaceuticals company. The stock of Sunesis Pharma ended the previous year at a price of $1.99 per share. As of Apr 16, 2021, the stock price has reached $5.32 apiece, which indicates a change of 167.34 percent making the company rank among the top performing stocks of the Biotech for the year 2021 till date. At the end of the last year, company's market capitalization stood at $36.01 million. It has now changed to $96.34 million as of writing. Sunesis Pharma continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and several other broader level multi-cap market indicators.
Immunome, Inc.
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Immunome, Inc.. Based on the market-cap change from $102.04 million to $256.47 million during the given months of the year 2021 and the share price change from $9.68 per share to a price of $24.06 per share as of Apr 16, 2021, Immunome, Inc. (IMNM) was successful in generating YTD returns of 148.55 percentage. Standing at the number ten rank in the top performing list of Biotech stocks, the Exton, United States-based Immunome, Inc. is categorized as the Biotechnology sub-sector business which falls under the larger Healthcare sector.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.